EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Changes in insulin resistance following antidepressant treatment mediate response in major depressive disorder

Houman Rashidian iD, Mehala Subramaniapillai, Caroline Park, Orly Lipsitz iD, Hannah Zuckerman, Bing Cao, Yena Lee, Hartej Gill iD, Roger Nelson Rodrigues iD, Joshua D Di Vincenzo iD, Michelle Iacobucci, Saja Jaberi und 3 weitere

Journal of Psychopharmacology · 2023-03 · 37 (3) · 313-317

DOI: 10.1177/02698811221132473 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Psychopharmacology, online erschienen am 15.11.2022. Verfasst von Houman Rashidian und 14 weiteren Autor:innen. Beteiligte Einrichtung: Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario. Hauptthemen laut MEDLINE: Major Depressive Disorder, Insulin Resistance. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Brain and Cognition Discovery Foundation by Lundbeck, Denmark.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Insulin resistance (IR) is a potential predictor of antidepressant treatment response.

Aims

We assess changes in IR after antidepressant treatment and whether these changes have any effect on treatment response. Also, to see whether changes in IR mediates relationship between C-reactive protein (CRP) and antidepressant efficacy.

Methods

This is a secondary analysis of an 8-week, open-label clinical trial with 95 adults experiencing a major depressive episode. Response to vortioxetine was measured using the Montgomery–Åsberg Depression Rating Scale (MADRS). Generalized estimating equation models were utilized for this intent-to-treat analysis.

Results

When adjusted for age, sex, and body mass index, there was a significant increase in IR following treatment in the overall sample (p = 0.035). This finding was detected in treatment non-responders (p = 0.019), whereas it was not observed in responders (p = 0.329). Mediation analysis revealed that change in IR during treatment was responsible for change in MADRS as well as the relationship between baseline CRP and treatment response.

Conclusions

Exacerbation of IR during antidepressant treatment mediated non-response. Conversely in treatment responders IR reduced. Like previous studies, baseline CRP moderated treatment response. This relationship was also mediated by changes in IR. These findings further elucidate the role of IR in terms of antidepressant response as well as potentially explain inflammation’s relationship with the latter.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Major Depressive DisorderInsulin ResistanceAdultHumansDouble-Blind MethodAntidepressive AgentsVortioxetineC-Reactive ProteinTreatment Outcome

Stichwörter der Autor:innen

CRPDepressionantidepressantinsulin resistancemajor depressive disordertreatment response

Substanzen

Antidepressive AgentsVortioxetineC-Reactive Protein

Autor:innen und Institutionen

  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario.
  • Department of Psychiatry, University of Toronto, Toronto, Ontario.
  • School of Psychology and Key Laboratory of Cognition and Personality (Ministry of Education), Southwest University, Chongqing, China.
  • Institute of Medical Science, University of Toronto, Toronto, Ontario.
  • Department of Pharmacology, University of Toronto, Toronto, Ontario.
  • Brain and Cognition Discovery Foundation, Toronto, Ontario.

ORCID-Profile: Houman Rashidian, Orly Lipsitz, Hartej Gill, Roger Nelson Rodrigues, Joshua D Di Vincenzo

Förderung

  • Brain and Cognition Discovery Foundation by Lundbeck, Denmark

Zitieren

APA

Rashidian, H., Subramaniapillai, M., Park, C., Lipsitz, O., Zuckerman, H., Cao, B., Lee, Y., Gill, H., Rodrigues, R. N., Di Vincenzo, J. D., Iacobucci, M., Jaberi, S., Rosenblat, J. D., McIntyre, R. S., & Mansur, R. B. (2023). Changes in insulin resistance following antidepressant treatment mediate response in major depressive disorder. Journal of Psychopharmacology, 37(3), 313-317. https://doi.org/10.1177/02698811221132473

Vancouver

Rashidian H, Subramaniapillai M, Park C, Lipsitz O, Zuckerman H, Cao B, et al. Changes in insulin resistance following antidepressant treatment mediate response in major depressive disorder. Journal of Psychopharmacology. 2023;37(3):313-317. doi:10.1177/02698811221132473

BibTeX
@article{Rashidian2023,
  author = {Rashidian, Houman and Subramaniapillai, Mehala and Park, Caroline and Lipsitz, Orly and Zuckerman, Hannah and Cao, Bing and Lee, Yena and Gill, Hartej and Rodrigues, Roger Nelson and Di Vincenzo, Joshua D and Iacobucci, Michelle and Jaberi, Saja and Rosenblat, Joshua D and McIntyre, Roger S and Mansur, Rodrigo B},
  title = {Changes in insulin resistance following antidepressant treatment mediate response in major depressive disorder},
  journal = {Journal of Psychopharmacology},
  year = {2023},
  volume = {37},
  number = {3},
  pages = {313--317},
  doi = {10.1177/02698811221132473}
}
Kostenlos starten →